In last trading session, Soleno Therapeutics Inc (NASDAQ:SLNO) saw 0.78 million shares changing hands with its beta currently measuring -2.65. Company’s recent per share price
Soleno Therapeutics Inc (NASDAQ:SLNO) has a beta value of -2.43 and has seen 1.04 million shares traded in the last trading session. The company, currently
In the last trading session, 0.96 million shares of the Soleno Therapeutics Inc (NASDAQ:SLNO) were traded, and its beta was -2.60. Most recently the company’s
In the last trading session, 1.08 million shares of the Soleno Therapeutics Inc (NASDAQ:SLNO) were traded, and its beta was -2.56. Most recently the company’s
In the latest trading session,, 0.73 million Soleno Therapeutics Inc (NASDAQ:SLNO) shares changed hands as the company’s beta touched -2.17. With the company’s most recent
During the recent session, Soleno Therapeutics Inc (NASDAQ:SLNO)’s traded shares were 1.04 million, with the beta value of the company hitting -2.25. At the last
In the last trading session, 1.63 million shares of the Soleno Therapeutics Inc (NASDAQ:SLNO) were traded, and its beta was -2.12. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
